Chase Chen is a seasoned regulatory affairs professional in the biopharmaceutical industry, currently serving as the Associate Director of Global Regulatory Affairs at D3 Bio since 2021. Previously, they held the positions of Associate Director of Global Regulatory Affairs at IASO BioTherapeutics, and Senior Manager at WuXi Biologics. Chase began their career at Amgen, where they specialized in regulatory strategies for biosimilars in the JAPAC region. They earned a Master of Science in Regulatory Affairs in Biotechnology from The Johns Hopkins University and a Bachelor of Science in Engineering Science from National Taiwan University.
This person is not in any teams
This person is not in any offices